Hysteroscope
Conditions
Interventions
The Oliceridine Group:General anesthesia is administered with oliceridine fumarate combined with propofol.
Sufentanil group:General anesthesia is administered with sufentanil combined with propofol.
Fentanyl group:General anesthesia is administered with fentanyl combined with propofol.
Sponsors
People's Hospital of Guilin City
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Screen patients aged between 18 and 65 years old (inclusive); (2) Subjects undergoing elective hysteroscopic polypectomy under intravenous general anesthesia; (3) ASA physical status classification I-II; (4) Body Mass Index (BMI) between 18 kg/m^2 and 30 kg/m^2 (inclusive); (5) Subjects fully understand the purpose, content, procedures and risks of this trial, voluntarily participate in the clinical trial and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients who cannot understand the Clinical Recovery Score (CRS) upon awakening and cannot cooperate with the evaluation; (2) Patients with a history of pain who have been taking painkillers for a long time; (3) Patients with severe cardiovascular diseases; (4) Patients allergic to oliceridine, fentanyl, or sufentanil; (5) Patients who withdraw from the study midway.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MOAA/S score;CRS Score;Postoperative Awakening Time;Time to complete recovery of consciousness; | — |
Secondary
| Measure | Time frame |
|---|---|
| respiratory rate;heart rate;blood pressure;oxygen saturation;Incidence Rate of Adverse Events; | — |
Countries
China
Contacts
Public ContactZhang Wenbin
People's Hospital of Guilin City
Outcome results
None listed